Subscribe to Search results

Micheal Martin, Minister for Health and Children, reached agreement with the Irish Haemophilia Society in relation to compensating HIV-infected haemophiliacs and their dependents.

Published on:

An individual described long delays and hard work involved in obtaining their medical records.

Published on:

Cressida Haughton described trying to obtain her late father's medical records as "like a battle of wills".

Published on:

The Public Records (Scotland) Act 1937 was passed.

Published on:

The Scottish Hospital Service Destruction of Records provided that hospital records (including blood transfusion records) had to be kept for 6 years after the patient's treatment at the hospital, or three years if the patient died at the hospital.

Published on:

The Retention and Disposal Schedule for England provided that records had to be kept 6 years after the conclusion of treatment or 6 years after the death of a patient.

Published on:

Regional Transfusion Directors' meeting recognised that "even if the incidence had reduced significantly since the last trial, because of self exclusion or for other reasons, the introduction of anti-HBc/ALT screening seemed very likely."

Published on:

Directors of Scottish National Blood Transfusion Service agreed that the UK Working Party on Transfusion Associated Hepatitis was the most appropriate body to pursue the implementation of surrogate testing.

Published on:

Dr Gunson was a proponent of the multi-centre study of Alanine Amino-transferase (ALT) and anti-hepatitis B core (anti-HBc) for the screening of blood donations in 1986.

Published on:

At the UK Directors Working Party meeting t had been agreed that "Screening should not be introduced at present especially in view of ARC [American Red Cross] postponement of core test start-up and reports of chaos in ALT screening programme."

Published on:

Dr Forrester stated in a letter that 'The position explicitly reached at the meeting [of UK Working Party on Transfusion-Associated Hepatitis] is to recommend research of no great significance or scientific interest because the prospect of research would serve to counter pressure from for example haemophiliacs and Haemophilia Directors to embark on an indirect and largely ineffective form of screening, which would also lose us a certain amount of perfectly harmless blood.'

Published on:

Dr Contreras wrote to Dr Smithies on the decision of the UK Working Party on Transfusion-Associated Hepatitis (WPTTH) to not fund a follow-up study. She stated that WPTTH had funded surrogate studies to determine NANBH rates in donors, and Dr Contreras wanted a follow-up study, not for patient safety, but to use transmission rates as a 'defence against "panic" requests to start surrogate screening'.

Published on:


At the meeting of the regional transfusion directors, Dr Gunson explained that a study beginning with transfused patients had been discussed but was felt to be "costly, difficult and not practical."

Published on:

The Working Party on Associated Hepatitis discussed the protocol for the anti-HBc/ALT screening trials.

Published on:


At a meeting of the SNBTS directors and haemophilia centre directors, Dr Forrester reported that in the US between 5 and 25 percent of transfusions led to the recipient contracting NANBH. It was said that the figure in the UK was approximately 2.5 percent and, in Scotland, that there were only one to five cases per annum.

Published on:

Material for the PMO report, supporting the view that transfusion associated NANBH was rare, "relatively benign" and generally not serious

Published on:

Dr Forrester wrote to Dr Moir seeking agreement in principle of CSO that funding for the scottish component of a research project can be sought

Published on:

Dr Moir wrote to Dr Forrester expressing reservations against providing funding for a research project involving one Scottish Transfusion Centre

Published on:

Dr Gunson wrote that it was incorrect that "no Scottish Centre was now being asked to participate" in the multi-centre study and that he was "dismayed" to read SNBT would be applying for funding for surrogate testing from 1 April 1988, as he had understood that "Scotland would not take unilateral action" in introducing surrogate testing without consultation with regional transfusion directors in England and Wales

Published on:

Professor Cash wrote to Dr Gunson, suggesting he should not take the content of the minutes in relation to surrogate testing "too seriously at this stage" as "the results of the UK study are unlikely to have a material affect [sic] on future operational practice."

Published on: